Interest in VAD Market Remains Strong; U.S. Market Development is Key
Analysts Piper Jaffray report: “We are incrementally more positive on neutral-rated Thoratec after attending the HFSA convention in Boston. We continue to view the under-penetration of VADs in the U.S. as an opportunity for Thoratec.”
2011 09-23 Interest in VAD market remains strong